Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

lutetium Lu-177 vivipotide tetraxetan

lutetium Lu-177 vivipotide tetraxetan
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Pluvicto INJECTION, INTRAVENOUS 1,000 MBq/mL      
Comments:

This radiological drug requires special facility criteria for the site of administration that Huntsville Hospital does not meet. Patients should be referred to an approved institution that meets the specific radiological criteria. 

 

Reviewed: March 2024, November 2024

Lutetium Lu 177 vipivotide tetraxetan (Pluvicto)

Last updated: Nov. 27, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved